CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionOperating margin is 27.6%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)
- FinancialsAltman Z-Score 5.41: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.70%Above 5Y avg (2.41%)
Annual Rate
TWD 10.01Paid annual
Payout Ratio
0.0%Sustainable
Payback Period
37.2 yr
Last Ex-Dividend
Aug 7, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
28.43BTWD890.94M · vs all stocks (USD)
Trailing P/E
15.93xvs Medical Instruments & Supplies peers
Revenue (TTM)
7.82BTWD245.03M · vs all stocks (USD)
Profit Margin
23.56%vs Medical Instruments & Supplies peers
Beta
0.7720xvs all stocks
52-Week Change
17.54%vs all stocks
Market Capitalization
28.43BTWD890.94M · vs all stocks (USD)
Enterprise Value
24.54BTWD769.04M · vs all stocks (USD)
Trailing P/E
15.93xvs Medical Instruments & Supplies peers
Forward P/E
12.89xvs Medical Instruments & Supplies peers
PEG Ratio
-4.76xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
3.69xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.49xvs Medical Instruments & Supplies peers
Enterprise to Revenue
3.14xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
8.44xvs Medical Instruments & Supplies peers
Gross Margin
53.33%vs Medical Instruments & Supplies peers
Profit Margin
23.56%vs Medical Instruments & Supplies peers
Operating Margin
27.65%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
8.11%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
16.51%vs Medical Instruments & Supplies peers
Revenue (TTM)
7.82BTWD245.03M · vs all stocks (USD)
Revenue per Share (TTM)
100.63TWDUpdated Aug 21, 2026Quarterly Revenue Growth
30.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
4.10BTWD128.42M · vs all stocks (USD)
EBITDA (TTM)
2.88BTWD90.16M · vs all stocks (USD)
Net Income (TTM)
1.84BTWD57.72M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
73.60%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
2.27BTWD71.29M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
366.33MTWD11.48M · vs all stocks (USD)
Trailing Annual Dividend Rate
10.01TWDUpdated Aug 21, 2026Trailing Annual Dividend Yield
2.70%vs all stocks
5-Year Average Dividend Yield
2.41%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
104.71MTWDFY2025 · Dec 31, 2025Revenue
7.04BTWDFY2025 · Dec 31, 2025Cost of Goods Sold
3.36BTWDFY2025 · Dec 31, 2025Gross Profit
3.68BTWDFY2025 · Dec 31, 2025Operating Income
1.81BTWD56.63M · vs all stocks (USD)
Pre-tax Income
2.02BTWDFY2025 · Dec 31, 2025Income Tax Expense
368.28MTWDFY2025 · Dec 31, 2025Net Income
1.65BTWDFY2025 · Dec 31, 2025EBIT
2.07BTWDFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.85BTWDFY2025 · Dec 31, 2025Research & Development
624.68MTWDFY2025 · Dec 31, 2025Selling, General & Administrative
1.25BTWDFY2025 · Dec 31, 2025Non-operating Interest Income
46.20MTWDFY2025 · Dec 31, 2025Non-operating Interest Expense
53.27MTWDFY2025 · Dec 31, 2025Minority Interests (P&L)
-22.42MTWDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025Operating Cash Flow
1.78BTWDFY2025 · Dec 31, 2025Free Cash Flow
304.06MTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.71BTWDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.02BTWDFY2025 · Dec 31, 2025Other Non-cash Items
6.23MTWDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-139.00MTWDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-109.63MTWDFY2025 · Dec 31, 2025Capital Expenditures
-1.47BTWDFY2025 · Dec 31, 2025Net Intangibles (CF)
-45.08MTWDFY2025 · Dec 31, 2025Purchase of Investments
-617.29MTWDFY2025 · Dec 31, 2025Other Investing Activity
-1.42MTWDFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.09BTWDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00TWDFY2025 · Dec 31, 2025Long-term Debt Payments
-94.85MTWDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
213.13MTWDFY2025 · Dec 31, 2025Common Dividends Paid
-858.00MTWDFY2025 · Dec 31, 2025Other Financing Charges
-8.82MTWDFY2025 · Dec 31, 2025Net Financing Cash Flow
-748.54MTWDFY2025 · Dec 31, 2025Shares Outstanding
77.47MSharesUpdated Aug 21, 2026Float Shares
39.81MSharesUpdated Aug 21, 2026% Held by Insiders
49.16%vs all stocks
% Held by Institutions
16.32%vs all stocks
Total Cash (MRQ)
4.32BTWD135.41M · vs all stocks (USD)
Total Cash per Share (MRQ)
56.26TWDUpdated Aug 21, 2026Total Debt (MRQ)
992.38MTWD31.10M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0851xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.48xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
150.52TWDUpdated Aug 21, 2026Total Assets
16.17BTWD506.85M · vs all stocks (USD)
Total Current Assets
6.54BTWDFY2025 · Dec 31, 2025Total Liabilities
4.44BTWDFY2025 · Dec 31, 2025Total Non-current Assets
9.64BTWDFY2025 · Dec 31, 2025Total Non-current Liabilities
620.70MTWDFY2025 · Dec 31, 2025Total Current Liabilities
3.82BTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.71BTWDFY2025 · Dec 31, 2025Other Short-term Investments
2.77BTWDFY2025 · Dec 31, 2025Accounts Receivable
938.06MTWDFY2025 · Dec 31, 2025Inventory
881.34MTWDFY2025 · Dec 31, 2025Accounts Payable
310.22MTWDFY2025 · Dec 31, 2025Short-term Debt
620.15MTWDFY2025 · Dec 31, 2025Other Current Liabilities
412.96MTWDFY2025 · Dec 31, 2025Long-term Debt
532.17MTWDFY2025 · Dec 31, 2025Other Non-current Liabilities
3.79MTWDFY2025 · Dec 31, 2025Common Stock (Book)
780.00MTWDFY2025 · Dec 31, 2025Retained Earnings
5.82BTWDFY2025 · Dec 31, 2025Total Shareholders' Equity
11.74BTWD367.77M · vs all stocks (USD)
52-Week Low
270.50TWDUpdated Aug 21, 202652-Week High
390.00TWDUpdated Aug 21, 202652-Week Change
17.54%vs all stocks
Beta
0.7720xvs all stocks
50-Day MA
346.68TWDUpdated Aug 21, 2026200-Day MA
307.13TWDUpdated Aug 21, 2026Avg 10-Day Volume
454.91KSharesUpdated Aug 21, 2026Avg 30-Day Volume
500.45KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
23.57TWDUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 27.6%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: 0.28Industry median: 0.12Industry P95: 0.27Peers compared: 65.00
Financial Health
Altman Z-Score 5.41: safe zoneNotable
Altman Z-Score: 5.41
High structural barrier to entryNotable
Barrier to Entry: 0.52
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Guangzhou Anyka Microelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Innovex International, Inc.
Tier 1ProductionThroughput-Bound ConversionRuleRisk
Jiangxi Black Cat Carbon Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Grieg Seafood ASA
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Jianbang New Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Wuxi Longsheng Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Zhengguang Industrial Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Myson Century Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Whirlpool China Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Anhui Tatfook Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Dexcom Inc.
1 interpretationCash Backing With Revenue And Income Streaks